220 related articles for article (PubMed ID: 37883798)
1. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L; Esteban O; Wesche J; Dobosz P; Broto M; Puig SR; Fuhrmann J; Torres R; Serra J; Llevadot R; Palicio M; Wang JJ; Gordon TP; Lindhoff-Last E; Hoffmann T; Alberio L; Langer F; Boehme C; Biguzzi E; Grosse L; Endres M; Liman T; Thiele T; Warkentin TE; Greinacher A
Blood; 2023 Dec; 142(26):2305-2314. PubMed ID: 37883798
[TBL] [Abstract][Full Text] [Related]
2. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.
Schönborn L; Thiele T; Esefeld M; El Debuch K; Wesche J; Seck SE; Kaderali L; Wolff M; Warkentin TE; Greinacher A
J Thromb Haemost; 2022 Nov; 20(11):2579-2586. PubMed ID: 36006172
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
Greinacher A; Warkentin TE
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
[TBL] [Abstract][Full Text] [Related]
4. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
[TBL] [Abstract][Full Text] [Related]
5. Laboratory testing for VITT antibodies.
Warkentin TE; Greinacher A
Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
[TBL] [Abstract][Full Text] [Related]
6. Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience.
Cesari F; Sorrentino S; Gori AM; Rogolino A; De Cristofaro R; Giusti B; Sticchi E; De Candia E; Marcucci R
Viruses; 2022 May; 14(6):. PubMed ID: 35746602
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
Warkentin TE; Greinacher A
Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
McGonagle D; De Marco G; Bridgewood C
J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
[TBL] [Abstract][Full Text] [Related]
10. [Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].
Atsushi Y
Rinsho Ketsueki; 2022; 63(9):1233-1241. PubMed ID: 36198549
[TBL] [Abstract][Full Text] [Related]
11. Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia.
Favaloro EJ; Pasalic L; Henry B; Lippi G
Pathology; 2022 Apr; 54(3):254-261. PubMed ID: 35125202
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of vaccine-induced thrombosis.
Marietta M; Coluccio V; Luppi M
Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
15. Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.
Favaloro EJ; Pasalic L
Methods Mol Biol; 2023; 2663():405-415. PubMed ID: 37204726
[TBL] [Abstract][Full Text] [Related]
16. [Novel disease entities due to antiplatelet factor 4 antibodies: HIT, aHIT, and VITT].
Yasumoto A
Rinsho Ketsueki; 2022; 63(5):454-462. PubMed ID: 35662171
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.
Platton S; Bartlett A; MacCallum P; Makris M; McDonald V; Singh D; Scully M; Pavord S
J Thromb Haemost; 2021 Aug; 19(8):2007-2013. PubMed ID: 33973336
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating anti-PF4 disorders: An overview.
Warkentin TE
Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.
Althaus K; Hron G; Strobel U; Abbate R; Rogolino A; Davidson S; Greinacher A; Bakchoul T
Thromb Res; 2013 Mar; 131(3):e85-90. PubMed ID: 23351665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
